Intralesional mumps, measles and rubella vaccine in the treatment of cutaneous warts

[1] Antigen injections are also thought to be associated with the proliferation of peripheral blood mononuclear cells that promote Th1 cytokine responses and further activate cytotoxic T-cells and natural killer cells to eradicate human papillomavirus-infected cells. [...]our experience of intralesional immunotherapy with mumps, measles, rubella vaccine suggests that it could be a promising treatment modality for patients with multiple cutaneous warts with the additional advantage of widespread and sustained effects against warts at distant sites.